Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-1

(Form Type)

 

Processa Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security
Type		   Security
Class Title		   Fee
Calculation Rule		   Amount to be
Registered		     Proposed
Maximum
Offering
Price Per
Unit		    

Proposed

Maximum

Aggregate

Offering

Price(1)

     Fee Rate     Amount of
Registration
Fee		  
Equity   Common Stock, par value $0.0001 per share(2)   Rule 457(o)                      $ 7,500,000  (3)   $ 0.00015310     $ 1,149  
Equity   Pre-Funded Warrants(4)   Rule 457(g)                                     -  
Equity   Common Stock issuable upon exercise of the Pre-Funded Warrants(2)   Rule 457(o)                                     (3)
Total Offering Amounts $ 7,500,000             $ 1,149  
Total Fees Previously Paid                      
Total Fee Offsets                      
Net Fee Due                 $ 1,149  

 

(1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
   
(2) Pursuant to Rule 416(a) under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
   
(3) The proposed maximum aggregate offering price of the common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants sold in the offering, and, as such, the proposed maximum aggregate offering price of the common stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $7,500,000.
   
(4) Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the warrants because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of the warrants.